-
2
-
-
17144436630
-
Combined modality therapy for non-small cell lung cancer, past, present, and future
-
D.W. Kim, and H. Choy Combined modality therapy for non-small cell lung cancer, past, present, and future Lung Cancer 42 2003 S35 S40
-
(2003)
Lung Cancer
, vol.42
-
-
Kim, D.W.1
Choy, H.2
-
3
-
-
84866904966
-
Personalized combined modality therapy for locally advanced non-small cell lung cancer
-
D.N. Kim, T.K. Nam, K.S. Choe, and H. Choy Personalized combined modality therapy for locally advanced non-small cell lung cancer Cancer Res Treat 44 2012 74 84
-
(2012)
Cancer Res Treat
, vol.44
, pp. 74-84
-
-
Kim, D.N.1
Nam, T.K.2
Choe, K.S.3
Choy, H.4
-
4
-
-
30544441331
-
Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume
-
K. Basaki, Y. Abe, M. Aoki, H. Kondo, Y. Hatayama, and S. Nakaji Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume Int J Radiat Oncol Biol Phys 64 2006 449 454
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 449-454
-
-
Basaki, K.1
Abe, Y.2
Aoki, M.3
Kondo, H.4
Hatayama, Y.5
Nakaji, S.6
-
5
-
-
0029778934
-
Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
-
R.O. Dillman, J. Herndon, S.L. Seagren, W.L. Eaton Jr, and M.R. Green Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1210-1215
-
-
Dillman, R.O.1
Herndon, J.2
Seagren, S.L.3
Eaton, Jr.W.L.4
Green, M.R.5
-
6
-
-
0025307174
-
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer
-
D.H. Johnson, L.H. Einhorn, and A. Bartolucci et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer Ann Intern Med 113 1990 33 38
-
(1990)
Ann Intern Med
, vol.113
, pp. 33-38
-
-
Johnson, D.H.1
Einhorn, L.H.2
Bartolucci, A.3
-
7
-
-
0028909219
-
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
-
W.T. Sause, C. Scott, and S. Taylor et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 198-205
-
-
Sause, W.T.1
Scott, C.2
Taylor, S.3
-
8
-
-
0022480114
-
Impact of tumor control on survival in carcinoma of the lung treated with irradiation
-
C.A. Perez, M. Bauer, S. Edelstein, B.W. Gillespie, and R. Birch Impact of tumor control on survival in carcinoma of the lung treated with irradiation Int J Radiat Oncol Biol Phys 12 1986 539 547
-
(1986)
Int J Radiat Oncol Biol Phys
, vol.12
, pp. 539-547
-
-
Perez, C.A.1
Bauer, M.2
Edelstein, S.3
Gillespie, B.W.4
Birch, R.5
-
9
-
-
0000326965
-
The toxicity of elective nodal irradiation in the definitive treatment of non-small cell carcinoma of the lung
-
A.T. Pu, A.S. Harrison, J.M. Robertson, J.A. Hayman, M.K. Martel, and R.K. TenHaken The toxicity of elective nodal irradiation in the definitive treatment of non-small cell carcinoma of the lung Int J Radiat Oncol Biol Phys 39 1997 196
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.39
, pp. 196
-
-
Pu, A.T.1
Harrison, A.S.2
Robertson, J.M.3
Hayman, J.A.4
Martel, M.K.5
Tenhaken, R.K.6
-
10
-
-
34249988209
-
A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer
-
S. Yuan, X. Sun, and M. Li et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer Am J Clin Oncol Cancer Clin Trials 30 2007 239 244
-
(2007)
Am J Clin Oncol Cancer Clin Trials
, vol.30
, pp. 239-244
-
-
Yuan, S.1
Sun, X.2
Li, M.3
-
11
-
-
0346238665
-
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
-
T. Le Chevalier, R. Arriagada, and C. Le Pechoux et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
-
(2004)
N Engl J Med
, vol.350
, pp. 351-360
-
-
Le Chevalier, T.1
Arriagada, R.2
Le Pechoux, C.3
-
12
-
-
77951804823
-
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages i to III non-small-cell lung cancer: Phase i results of RTOG 0117
-
J.D. Bradley, J. Moughan, and M.V. Graham et al. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117 Int J Radiat Oncol Biol Phys 77 2010 367 372
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 367-372
-
-
Bradley, J.D.1
Moughan, J.2
Graham, M.V.3
-
13
-
-
0036803119
-
High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial
-
J.G. Rosenman, J.S. Halle, and M.A. Socinski et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 348-356
-
-
Rosenman, J.G.1
Halle, J.S.2
Socinski, M.A.3
-
14
-
-
33745185115
-
Results of a phase i trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer
-
S.E. Schild, W.L. McGinnis, and D. Graham et al. Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1106 1111
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1106-1111
-
-
Schild, S.E.1
McGinnis, W.L.2
Graham, D.3
-
15
-
-
0036499649
-
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer
-
M.A. Socinski, M.J. Schell, and A. Peterman et al. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer J Clin Oncol 20 2002 1335 1343
-
(2002)
J Clin Oncol
, vol.20
, pp. 1335-1343
-
-
Socinski, M.A.1
Schell, M.J.2
Peterman, A.3
-
16
-
-
84858792325
-
Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. A Radiation Therapy Oncology Group analysis
-
M. Machtay, R. Paulus, and J. Moughan et al. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. A Radiation Therapy Oncology Group analysis J Thorac Oncol 7 2012 716 722
-
(2012)
J Thorac Oncol
, vol.7
, pp. 716-722
-
-
Machtay, M.1
Paulus, R.2
Moughan, J.3
-
17
-
-
84894452942
-
A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy +/- cetuximab for stage IIIa/IIIb non-small cell lung cancer: Preliminary findings on radiation dose in RTOG 0617 (late-breaking abstract 2)
-
Miami, FL
-
Bradley JPR, Komaki R, et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy +/- cetuximab for stage IIIa/IIIb non-small cell lung cancer: preliminary findings on radiation dose in RTOG 0617 (late-breaking abstract 2). 53rd Annual Meeting of the American Society of Radiation Oncology; 2011; Miami, FL.
-
(2011)
53rd Annual Meeting of the American Society of Radiation Oncology
-
-
Jpr, B.1
Komaki, R.2
-
18
-
-
80054072961
-
Sequential v concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410
-
W.J. Curran Jr, R. Paulus, and C.J. Langer et al. Sequential v concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1452-1460
-
-
Curran, Jr.W.J.1
Paulus, R.2
Langer, C.J.3
-
19
-
-
0036805582
-
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in stage III non-small-cell lung cancer
-
S.E. Schild, P.J. Stella, and S.M. Geyer et al. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 54 2002 370 378
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 370-378
-
-
Schild, S.E.1
Stella, P.J.2
Geyer, S.M.3
-
20
-
-
0030737527
-
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
-
M. Saunders, S. Dische, A. Barrett, A. Harvey, D. Gibson, and M. Parmar Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial Lancet 350 1997 161 165
-
(1997)
Lancet
, vol.350
, pp. 161-165
-
-
Saunders, M.1
Dische, S.2
Barrett, A.3
Harvey, A.4
Gibson, D.5
Parmar, M.6
-
21
-
-
20544435485
-
Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer
-
C.P. Belani, W. Wang, and D.H. Johnson et al. Phase III study of the eastern cooperative oncology group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer J Clin Oncol 23 2005 3760 3767
-
(2005)
J Clin Oncol
, vol.23
, pp. 3760-3767
-
-
Belani, C.P.1
Wang, W.2
Johnson, D.H.3
-
22
-
-
84864564911
-
Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-analysis
-
A. Mauguen, C. Le Pechoux, and M.I. Saunders et al. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis J Clin Oncol 30 2012 2788 2797
-
(2012)
J Clin Oncol
, vol.30
, pp. 2788-2797
-
-
Mauguen, A.1
Le Pechoux, C.2
Saunders, M.I.3
-
23
-
-
67651124771
-
A phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable stage III non-small-cell lung cancer: Results of Korean Radiation Oncology Group 0301 study
-
K.H. Cho, S.J. Ahn, and H.R. Pyo et al. A phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study Int J Radiat Oncol Biol Phys 74 2009 1397 1404
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.74
, pp. 1397-1404
-
-
Cho, K.H.1
Ahn, S.J.2
Pyo, H.R.3
-
24
-
-
84894505501
-
Soccar: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC
-
J. Maguire, N. O'Rourke, and C. Peedell et al. Soccar: sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC J Thorac Oncol 6 2011 S1561 S1562
-
(2011)
J Thorac Oncol
, vol.6
-
-
Maguire, J.1
O'Rourke, N.2
Peedell, C.3
-
25
-
-
0029113383
-
Stage i nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
-
D.H. Harpole Jr., J.E. Herndon 2nd, W.G. Young Jr., W.G. Wolfe, and D.C. Sabiston Jr Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence Cancer 76 1995 787 796
-
(1995)
Cancer
, vol.76
, pp. 787-796
-
-
Harpole, Jr.D.H.1
Herndon II, J.E.2
Young, Jr.W.G.3
Wolfe, W.G.4
Sabiston, Jr.D.C.5
-
26
-
-
33747852920
-
Local recurrence following initial resection of NSCLC: Salvage is possible with radiation therapy
-
C.R. Kelsey, R.W. Clough, and L.B. Marks Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy Cancer J 12 2006 283 288
-
(2006)
Cancer J
, vol.12
, pp. 283-288
-
-
Kelsey, C.R.1
Clough, R.W.2
Marks, L.B.3
-
27
-
-
0033993435
-
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
-
W. Sause, P. Kolesar, and S. Taylor et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364
-
(2000)
Chest
, vol.117
, pp. 358-364
-
-
Sause, W.1
Kolesar, P.2
Taylor, S.3
-
28
-
-
4244045520
-
Non-small Cell Lung Cancer Collaborative Group
-
Chemotherapy for non-small cell lung cancer
-
Chemotherapy for non-small cell lung cancer Non-small Cell Lung Cancer Collaborative Group Cochrane Database Syst Rev 2000 CD002139
-
(2000)
Cochrane Database Syst Rev
, pp. 002139
-
-
-
29
-
-
34247212838
-
Management of unresected stage III non-small cell lung cancer: A systematic review
-
Lung Cancer Disease Site Group of Cancer Care Ontario's Program in evidence-based cancer
-
G. Okawara, J.A. Mackay, W.K. Evans, Y.C. Ung Lung Cancer Disease Site Group of Cancer Care Ontario's Program in evidence-based cancer Management of unresected stage III non-small cell lung cancer: a systematic review J Thorac Oncol 1 2006 377 393
-
(2006)
J Thorac Oncol
, vol.1
, pp. 377-393
-
-
Okawara, G.1
Mackay, J.A.2
Evans, W.K.3
Ung, Y.C.4
-
30
-
-
0032858243
-
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
-
K. Furuse, M. Fukuoka, and M. Kawahara et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
-
(1999)
J Clin Oncol
, vol.17
, pp. 2692-2699
-
-
Furuse, K.1
Fukuoka, M.2
Kawahara, M.3
-
31
-
-
57449090435
-
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: The Hoosier Oncology Group and US Oncology
-
N. Hanna, M. Neubauer, and C. Yiannoutsos et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and US Oncology J Clin Oncol 26 2008 5755 5760
-
(2008)
J Clin Oncol
, vol.26
, pp. 5755-5760
-
-
Hanna, N.1
Neubauer, M.2
Yiannoutsos, C.3
-
32
-
-
34248651350
-
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B
-
E.E. Vokes, J.E. Herndon II, and M.J. Kelley et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 2007 1698 1704
-
(2007)
J Clin Oncol
, vol.25
, pp. 1698-1704
-
-
Vokes, E.E.1
Herndon, I.I.J.E.2
Kelley, M.J.3
-
33
-
-
77957287051
-
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105
-
N. Yamamoto, K. Nakagawa, and Y. Nishimura et al. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105 J Clin Oncol 28 2010 3739 3745
-
(2010)
J Clin Oncol
, vol.28
, pp. 3739-3745
-
-
Yamamoto, N.1
Nakagawa, K.2
Nishimura, Y.3
-
34
-
-
84862802175
-
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer
-
L. Wang, S. Wu, and G. Ou et al. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer Lung Cancer 77 2012 89 96
-
(2012)
Lung Cancer
, vol.77
, pp. 89-96
-
-
Wang, L.1
Wu, S.2
Ou, G.3
-
35
-
-
70350225538
-
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 study
-
T. Ciuleanu, T. Brodowicz, and C. Zielinski et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Lancet 374 2009 1432 1440
-
(2009)
Lancet
, vol.374
, pp. 1432-1440
-
-
Ciuleanu, T.1
Brodowicz, T.2
Zielinski, C.3
-
36
-
-
64049115311
-
The differential efficacy of pemetrexed according to NSCLC histology: A review of two phase III studies
-
G. Scagliotti, N. Hanna, and F. Fossella et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies Oncologist 14 2009 253 263
-
(2009)
Oncologist
, vol.14
, pp. 253-263
-
-
Scagliotti, G.1
Hanna, N.2
Fossella, F.3
-
37
-
-
84875944153
-
New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer
-
J.K. Salama, and E.E. Vokes New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer J Clin Oncol 31 2013 1029 1038
-
(2013)
J Clin Oncol
, vol.31
, pp. 1029-1038
-
-
Salama, J.K.1
Vokes, E.E.2
-
38
-
-
24944542868
-
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol
-
C.P. Belani, H. Choy, and P. Bonomi et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol J Clin Oncol 23 2005 5883 5891
-
(2005)
J Clin Oncol
, vol.23
, pp. 5883-5891
-
-
Belani, C.P.1
Choy, H.2
Bonomi, P.3
-
39
-
-
0038688474
-
Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504
-
D.R. Gandara, K. Chansky, and K.S. Albain et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 J Clin Oncol 21 2003 2004 2010
-
(2003)
J Clin Oncol
, vol.21
, pp. 2004-2010
-
-
Gandara, D.R.1
Chansky, K.2
Albain, K.S.3
-
40
-
-
84894422219
-
GILT phase III study: Concomitant radiotherapy (RT) with oral vinorelbine (NVBo) plus cisplatin (P) followed by consolidation (C) with NVBo+P plus BSC or BSC alone in stage (st) III NSCLC
-
R.M. Huber, W. Engel-Riedel, and J. Kollmeier et al. GILT phase III study: concomitant radiotherapy (RT) with oral vinorelbine (NVBo) plus cisplatin (P) followed by consolidation (C) with NVBo+P plus BSC or BSC alone in stage (st) III NSCLC Onkologie 35 2012 167 168
-
(2012)
Onkologie
, vol.35
, pp. 167-168
-
-
Huber, R.M.1
Engel-Riedel, W.2
Kollmeier, J.3
-
41
-
-
34250832918
-
Effect of paclitaxel-carboplatin (PC) consolidation chemotherapy after weekly PC concurrent chemo-radiotherapy (CCR) for patients with locally advanced non-small cell lung cancer (LA-NSCLC): 3-year definitive results of the B001-phase III GERCOR-study
-
392S-S
-
P. Colin, N. Jovenin, and G. Ganem et al. Effect of paclitaxel- carboplatin (PC) consolidation chemotherapy after weekly PC concurrent chemo-radiotherapy (CCR) for patients with locally advanced non-small cell lung cancer (LA-NSCLC): 3-year definitive results of the B001-phase III GERCOR-study J Clin Oncol 24 2006 392S-S
-
(2006)
J Clin Oncol
, vol.24
-
-
Colin, P.1
Jovenin, N.2
Ganem, G.3
-
43
-
-
16544374983
-
Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy
-
P. Huguenin, K.T. Beer, and A. Allal et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy J Clin Oncol 22 2004 4665 4673
-
(2004)
J Clin Oncol
, vol.22
, pp. 4665-4673
-
-
Huguenin, P.1
Beer, K.T.2
Allal, A.3
-
44
-
-
0041563993
-
The epidermal growth factor receptor mediates radioresistance
-
K. Liang, K.K. Ang, L. Milas, N. Hunter, and Z. Fan The epidermal growth factor receptor mediates radioresistance Int J Radiat Oncol Biol Phys 57 2003 246 254
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 246-254
-
-
Liang, K.1
Ang, K.K.2
Milas, L.3
Hunter, N.4
Fan, Z.5
-
45
-
-
0031054990
-
Epidermal growth factor receptor family and chemosensitization
-
J. Mendelsohn, and Z. Fan Epidermal growth factor receptor family and chemosensitization J Natl Cancer Inst 89 1997 341 343
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 341-343
-
-
Mendelsohn, J.1
Fan, Z.2
-
46
-
-
0034059884
-
Signal transduction and cellular radiation responses
-
R.K. Schmidt-Ullrich, P. Dent, S. Grant, R.B. Mikkelsen, and K. Valerie Signal transduction and cellular radiation responses Radiat Res 153 2000 245 257
-
(2000)
Radiat Res
, vol.153
, pp. 245-257
-
-
Schmidt-Ullrich, R.K.1
Dent, P.2
Grant, S.3
Mikkelsen, R.B.4
Valerie, K.5
-
47
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
J.A. Bonner, P.M. Harari, and J. Giralt et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
48
-
-
79959195283
-
Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324
-
G.R. Blumenschein Jr, R. Paulus, and W.J. Curran et al. Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324 J Clin Oncol 29 2011 2312 2318
-
(2011)
J Clin Oncol
, vol.29
, pp. 2312-2318
-
-
Blumenschein, Jr.G.R.1
Paulus, R.2
Curran, W.J.3
-
49
-
-
80051742422
-
Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B Trial 30407
-
R. Govindan, J. Bogart, and T. Stinchcombe et al. Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B Trial 30407 J Clin Oncol 29 2011 3120 3125
-
(2011)
J Clin Oncol
, vol.29
, pp. 3120-3125
-
-
Govindan, R.1
Bogart, J.2
Stinchcombe, T.3
-
50
-
-
34748831698
-
Biology of interactions: Antiepidermal growth factor receptor agents
-
P.M. Harari, G.W. Allen, and J.A. Bonner Biology of interactions: antiepidermal growth factor receptor agents J Clin Oncol 25 2007 4057 4065
-
(2007)
J Clin Oncol
, vol.25
, pp. 4057-4065
-
-
Harari, P.M.1
Allen, G.W.2
Bonner, J.A.3
-
51
-
-
0012381722
-
Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer
-
M. Fukuoka, S. Yano, and G. Giaccone et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 2003 2237 2246
-
(2003)
J Clin Oncol
, vol.21
, pp. 2237-2246
-
-
Fukuoka, M.1
Yano, S.2
Giaccone, G.3
-
52
-
-
0142055937
-
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - A randomized trial
-
M.G. Kris, R.B. Natale, and R.S. Herbst et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer - a randomized trial JAMA 290 2003 2149 2158
-
(2003)
JAMA
, vol.290
, pp. 2149-2158
-
-
Kris, M.G.1
Natale, R.B.2
Herbst, R.S.3
-
53
-
-
1542503746
-
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1
-
G. Giaccone, R.S. Herbst, and C. Manegold et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT1 J Clin Oncol 22 2004 777 784
-
(2004)
J Clin Oncol
, vol.22
, pp. 777-784
-
-
Giaccone, G.1
Herbst, R.S.2
Manegold, C.3
-
54
-
-
1542713370
-
Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2
-
R.S. Herbst, G. Giaccone, J.H. Schiller, R.B. Natale, and V. Miller Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial - INTACT 2 J Clin Oncol 22 2004 785 794
-
(2004)
J Clin Oncol
, vol.22
, pp. 785-794
-
-
Herbst, R.S.1
Giaccone, G.2
Schiller, J.H.3
Natale, R.B.4
Miller, V.5
-
55
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
T.J. Lynch, D.W. Bell, and R. Sordella et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
56
-
-
2342624080
-
EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
-
J.G. Paez, P.A. Janne, and J.C. Lee et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
-
(2004)
Science
, vol.304
, pp. 1497-1500
-
-
Paez, J.G.1
Janne, P.A.2
Lee, J.C.3
-
57
-
-
45149102984
-
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023
-
K. Kelly, K. Chansky, and L.E. Gaspar et al. Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 J Clin Oncol 26 2008 2450 2456
-
(2008)
J Clin Oncol
, vol.26
, pp. 2450-2456
-
-
Kelly, K.1
Chansky, K.2
Gaspar, L.E.3
-
58
-
-
77956267159
-
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis Cancer and Leukemia Group B (CALEB) 30106, a CALGB-stratified phase II trial
-
N. Ready, P.A. Jaenne, and J. Bogart et al. Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis Cancer and Leukemia Group B (CALEB) 30106, a CALGB-stratified phase II trial J Thorac Oncol 5 2010 1382 1390
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1382-1390
-
-
Ready, N.1
Jaenne, P.A.2
Bogart, J.3
-
59
-
-
58149132003
-
Phase i trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer
-
N.W. Choong, A.M. Mauer, and D.J. Haraf et al. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer J Thorac Oncol 3 2008 1003 1011
-
(2008)
J Thorac Oncol
, vol.3
, pp. 1003-1011
-
-
Choong, N.W.1
Mauer, A.M.2
Haraf, D.J.3
-
60
-
-
34248140107
-
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial
-
U. Gatzemeier, A. Pluzanska, and A. Szczesna et al. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial J Clin Oncol 25 2007 1545 1552
-
(2007)
J Clin Oncol
, vol.25
, pp. 1545-1552
-
-
Gatzemeier, U.1
Pluzanska, A.2
Szczesna, A.3
-
61
-
-
24944440830
-
TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
-
R.S. Herbst, D. Prager, and R. Hermann et al. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer J Clin Oncol 23 2005 5892 5899
-
(2005)
J Clin Oncol
, vol.23
, pp. 5892-5899
-
-
Herbst, R.S.1
Prager, D.2
Hermann, R.3
-
62
-
-
22044445517
-
Erlotinib in previously treated non-small-cell lung cancer
-
F.A. Shepherd, J.R. Pereira, and T. Ciuleanu et al. Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
-
(2005)
N Engl J Med
, vol.353
, pp. 123-132
-
-
Shepherd, F.A.1
Pereira, J.R.2
Ciuleanu, T.3
-
63
-
-
84863892117
-
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial
-
P.A. Janne, X. Wang, and M.A. Socinski et al. Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial J Clin Oncol 30 2012 2063 2069
-
(2012)
J Clin Oncol
, vol.30
, pp. 2063-2069
-
-
Janne, P.A.1
Wang, X.2
Socinski, M.A.3
-
64
-
-
18244419396
-
Combined effects of angiostatin and ionizing radiation in antitumour therapy
-
H.J. Mauceri, N.N. Hanna, and M.A. Beckett et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
-
(1998)
Nature
, vol.394
, pp. 287-291
-
-
Mauceri, H.J.1
Hanna, N.N.2
Beckett, M.A.3
-
65
-
-
11844254414
-
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
-
R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
-
(2005)
Science
, vol.307
, pp. 58-62
-
-
Jain, R.K.1
-
66
-
-
11144354392
-
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
-
C.G. Willett, Y. Boucher, and E. di Tomaso et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nature Med 10 2004 145 147
-
(2004)
Nature Med
, vol.10
, pp. 145-147
-
-
Willett, C.G.1
Boucher, Y.2
Di Tomaso, E.3
-
67
-
-
73949149605
-
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
-
D.R. Spigel, J.D. Hainsworth, and D.A. Yardley et al. Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab J Clin Oncol 28 2010 43 48
-
(2010)
J Clin Oncol
, vol.28
, pp. 43-48
-
-
Spigel, D.R.1
Hainsworth, J.D.2
Yardley, D.A.3
-
68
-
-
0032708238
-
Thalidomide - A revival story
-
N. Raje, and K. Anderson Thalidomide - a revival story N Engl J Med 341 1999 1606 1609
-
(1999)
N Engl J Med
, vol.341
, pp. 1606-1609
-
-
Raje, N.1
Anderson, K.2
-
69
-
-
84863116718
-
Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: The ECOG 3598 study
-
T. Hoang, S.E. Dahlberg, and J.H. Schiller et al. Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study J Clin Oncol 30 2012 616 622
-
(2012)
J Clin Oncol
, vol.30
, pp. 616-622
-
-
Hoang, T.1
Dahlberg, S.E.2
Schiller, J.H.3
-
70
-
-
34547638047
-
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
561-U3
-
M. Soda, Y.L. Choi, and M. Enomoto et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561-U3
-
(2007)
Nature
, vol.448
-
-
Soda, M.1
Choi, Y.L.2
Enomoto, M.3
-
71
-
-
82555205501
-
New strategies for treatment of ALK-rearranged non-small cell lung cancers
-
T. Sasaki, and P.A. Jaenne New strategies for treatment of ALK-rearranged non-small cell lung cancers Clin Cancer Res 17 2011 7213 7218
-
(2011)
Clin Cancer Res
, vol.17
, pp. 7213-7218
-
-
Sasaki, T.1
Jaenne, P.A.2
-
72
-
-
26844536978
-
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
-
E.H. Romond, E.A. Perez, and J. Bryant et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
-
(2005)
N Engl J Med
, vol.353
, pp. 1673-1684
-
-
Romond, E.H.1
Perez, E.A.2
Bryant, J.3
-
74
-
-
20344362646
-
Importance of local control in an era of systemic therapy
-
S. Hellman, and R.R. Weichselbaum Importance of local control in an era of systemic therapy Nat Clin Pract Oncol 2 2005 60 61
-
(2005)
Nat Clin Pract Oncol
, vol.2
, pp. 60-61
-
-
Hellman, S.1
Weichselbaum, R.R.2
-
75
-
-
84876510572
-
A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer
-
P.R. Patel, D.S. Yoo, Y. Niibe, J.J. Urbanic, and J.K. Salama A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer Pulm Med 2012 2012 480961
-
(2012)
Pulm Med
, vol.2012
, pp. 480961
-
-
Patel, P.R.1
Yoo, D.S.2
Niibe, Y.3
Urbanic, J.J.4
Salama, J.K.5
-
76
-
-
84876094979
-
Extracranial oligometastases: A subset of metastases curable with stereotactic radiotherapy
-
K.S. Corbin, S. Hellman, and R.R. Weichselbaum Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy J Clin Oncol 31 2013 1384 1390
-
(2013)
J Clin Oncol
, vol.31
, pp. 1384-1390
-
-
Corbin, K.S.1
Hellman, S.2
Weichselbaum, R.R.3
-
77
-
-
16644368518
-
Analysis of further disease progression in metastatic non-small cell lung cancer: Implications for locoregional treatment
-
N. Mehta, A.M. Mauer, and S. Hellman et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment Int J Oncol 25 2004 1677 1683
-
(2004)
Int J Oncol
, vol.25
, pp. 1677-1683
-
-
Mehta, N.1
Mauer, A.M.2
Hellman, S.3
-
78
-
-
65549125983
-
Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis
-
K.E. Rusthoven, S.F. Hammerman, B.D. Kavanagh, M.J. Birtwhistle, M Stares, and D.R Camidge Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis Acta Oncol 48 2009 578 583
-
(2009)
Acta Oncol
, vol.48
, pp. 578-583
-
-
Rusthoven, K.E.1
Hammerman, S.F.2
Kavanagh, B.D.3
Birtwhistle, M.J.4
Stares, M.5
Camidge, D.R.6
-
79
-
-
84927167657
-
A Phase II trial of second-line erlontinib in combination with stereotactic body radiation therapy (SBRT) for patients with metastatic non-small cell lung cancer (NSCLC)
-
Iyengar P, Kavanagh B, Smith I, Ahn C, Gerber D, Dowell J, et. al. A Phase II trial of second-line erlontinib in combination with stereotactic body radiation therapy (SBRT) for patients with metastatic non-small cell lung cancer (NSCLC). J Clin Oncol. 2013;31:15 suppl:8074
-
(2013)
J Clin Oncol.
, vol.31
, Issue.15 SUPPL.
, pp. 8074
-
-
Iyengar, P.1
Kavanagh, B.2
Smith, I.3
Ahn, C.4
Gerber, D.5
Dowell, J.6
-
80
-
-
84875936184
-
Harnessing the immune system for the treatment of non-small-cell lung cancer
-
J.R. Brahmer Harnessing the immune system for the treatment of non-small-cell lung cancer J Clin Oncol 31 2013 1021 1028
-
(2013)
J Clin Oncol
, vol.31
, pp. 1021-1028
-
-
Brahmer, J.R.1
|